RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+13.7%
5Y CAGR+18.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+13.7%/yr
vs +40.6%/yr prior
5Y CAGR
+18.4%/yr
Recent deceleration
Acceleration
-26.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
8 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$29.76M+3.0%
2024$28.88M+10.8%
2023$26.06M+28.8%
2022$20.24M+26.2%
2021$16.04M+25.6%
2020$12.77M+46.5%
2019$8.72M+68.3%
2018$5.18M+39.5%
2017$3.71M-